跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 1,527 条关于
“OncoZenge AB”
全部
1,527
临床试验
285
药物
378
机构
499
资讯
365
去年
OncoZenge Secures $2.9 Million Investment to Advance Phase 3 Trial of BupiZenge for Oral Mucositis Pain
去年
OncoZenge Partners with Meribel Pharma for BupiZenge Phase 3 Manufacturing
去年
OncoZenge Bolsters Phase 3 Team for BupiZenge™ as Company Prepares for Pivotal Trial in Oral Mucositis
9个月前
OncoZenge Submits Phase III Clinical Trial Application for BupiZenge in Cancer-Related Oral Pain
2年前
Ensysce Biosciences Advances Novel Analgesics PF614 and PF614-MPAR Towards Phase 3 Trials
去年
OncoZenge and Molteni Farmaceutici Partner for BupiZenge Commercialization in Europe
去年
OncoZenge Secures Funding for European Phase III Cancer Trial as Alzinova Advances Alzheimer's Program
9个月前
AskBio's Gene Therapies AB-1005 and AB-1002 Receive Japan's Pioneering Regenerative Medical Product Designation
2年前
Redosing Diamyd® Shows Promise in Stabilizing Insulin Production in Type 1 Diabetes
去年
EMA Confirms Negative Stance on Masitinib for Amyotrophic Lateral Sclerosis
第 1 页,共 37 页
上一页
下一页